Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening

被引:14
|
作者
Gram, IT
Macaluso, M
Stalsberg, H
机构
[1] Univ Tromso, Inst Community Med, Tromso, Norway
[2] Univ Tromso, Inst Med Biol, Tromso, Norway
[3] Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
关键词
cervical intraepithelial neoplasia; Norway; Pap-smear; screening history;
D O I
10.1034/j.1600-0412.1998.770219.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. To investigate the influence of screening history on the diagnosis of cervical intraepithelial neoplasia grade three (CIN III) and cervical cancer in an opportunistic screening program. Design. Follow-up study of women with a negative Pap-smear at entry. Materials. Records from 41212 women pertaining to cervical specimens in the Pathology Registry of the University Hospital in Tromso. Results. During the 175,673 person-years (pyr) of observation, 396 incident cases (379 of CIN III and 17 of cervical cancer) were identified. The age specific incidence rate was highest among women who were 25 to 29 years old (396 per 100,000 pyr). A Poisson multiple regression model yielded statistically significant positive associations between time since last negative Pap-smear and the incidence of CIN III and cervical cancer. Most CIN III cases were diagnosed subsequently to a CIN I or CIN II diagnosis. Including only women with a CIN III diagnosis directly after a negative Pap-smear in the analyses revealed that women with less than two years (Relative rate (RR)=1.0; 95% CI 0.7-1.4) and three years (RR=0.8; 95% CI 0.4-1.4) since their last negative Pap-smear were not at an increased risk compared with the women with a negative Pap-smear within the last year. Women with three or more years since their last negative Pap-smear were at an increased risk (RR=1.3; 95% CI 0.6-3.2) for CIN III. No meaningful association between number of negative specimens and the risk of CIN III was revealed. Conclusion. This study indicates that time since last negative Pap-smear does, while number of such does not, influence the risk of CIN III and cervical cancer in an opportunistic screening.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 50 条
  • [21] CD34+ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri
    Barth, PJ
    Ramaswamy, A
    Moll, R
    VIRCHOWS ARCHIV, 2002, 441 (06) : 564 - 568
  • [22] CLINICAL MANAGEMENT OF PATIENTS WITH INVASIVE CERVICAL-CANCER FOLLOWING A NEGATIVE PAP SMEAR
    SCHWARTZ, PE
    MERINO, MJ
    CURNEN, MGM
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1988, 61 (04): : 327 - 338
  • [23] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Laura Reques
    Camille Rolland
    Anne Lallemand
    Najat Lahmidi
    Ezequiel Aranda-Fernández
    Antonio Lazzarino
    Julie Bottero
    Françoise Hamers
    Christine Bergeron
    Ken Haguenoer
    Guy Launoy
    Niklas Luhmann
    BMC Women's Health, 21
  • [24] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Reques, Laura
    Rolland, Camille
    Lallemand, Anne
    Lahmidi, Najat
    Aranda-Fernandez, Ezequiel
    Lazzarino, Antonio
    Bottero, Julie
    Hamers, Francoise
    Bergeron, Christine
    Haguenoer, Ken
    Launoy, Guy
    Luhmann, Niklas
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [25] HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia
    Sarian, LO
    Derchain, SFM
    Andrade, LAA
    Tambascia, J
    Morais, SS
    Syrjänen, KJ
    GYNECOLOGIC ONCOLOGY, 2004, 94 (01) : 181 - 186
  • [26] IS VACCINATION AGAINST THE HUMAN PAPILLOMAVIRUS FOR PREVENTION OF THE CERVIX UTERI CANCER INDICATED IN PAKISTAN WHERE THERE IS NO PAP SMEAR CERVICAL CANCER SCREENING PROGRAM-A PUBLIC HEALTH PERSPECTIVE?
    Badar, F.
    Anwar, N.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A416 - A416
  • [27] The cervical cancer screening programme in Norway 1992-2000:: changes in Pap smear coverage and incidence of cervical cancer
    Nygård, JF
    Skare, GB
    Thoresen, SO
    JOURNAL OF MEDICAL SCREENING, 2002, 9 (02) : 86 - 91
  • [28] Risk of invasive cervical cancer and cervical intraepithelial neoplasia grade III in central Italy by area of birth
    Crocetti, Emanuele
    Manneschi, Gianfranco
    Visioli, Carmen Beatriz
    Zappa, Marco
    JOURNAL OF MEDICAL SCREENING, 2010, 17 (02) : 87 - 90
  • [29] Incidences of Cervical Intraepithelial Neoplasia 2-3 or Cancer Pathologic Diagnoses in Patients with a High Grade Squamous Intraepithelial Lesion Pap Smear Attending a Colposcopy Clinic at Srinagarind Hospital
    Ingkapairoj, Navakorn
    Luanratanakorn, Sanguanchoke
    Chumworathayi, Bandit
    Kietpeerakool, Chumnan
    Supoken, Amornrat
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6203 - 6206
  • [30] Performance of Pap smear and human papilloma virus testing in the follow-up of women with cervical intraepithelial neoplasia grade 1 managed conservatively
    Santos, ALF
    Derchain, SFM
    Sarian, LO
    Martins, MR
    Morais, SS
    Syrjänen, KJ
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2006, 85 (04) : 444 - 450